ConductScience.org, home

Paper28069641

Differential Impact of Chronic Hyperglycemia on Humoral Versus Cellular Primary Alloimmunity.

Bishop NH and 4 others. Diabetes, 2017. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Differential Impact of Chronic Hyperglycemia on Humoral Versus Cellular Primary Alloimmunity. Papers, record 28069641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28069641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Differential Impact of Chronic Hyperglycemia on Humoral Versus Cellular Primary Alloimmunity.
PubMed
Journal
Diabetes
PubMed
Year
2017
PubMed
Publication types
Comparative Study, Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.13
iCite
Revised in PubMed
2018-11-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bishop NHNicholas H
2Nelsen MKMichelle K
3Beard KSK Scott
4Coulombe MMarilyne
5Gill RGRonald G

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes MellitusMajor topic
Graft RejectionMajor topic
HyperglycemiaMajor topic
Immunity, CellularMajor topic
Immunity, HumoralMajor topic
T-LymphocytesMajor topic
Animals
Insulin
Islets of Langerhans Transplantation
Male
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mutation
Transplantation, Homologous

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DK099187NIDDK NIH HHSUnited StatesR01DK099187PubMed and NIHNIH RePORTER
T32 AI007405NIAID NIH HHSUnited StatesT32AI007405PubMed and NIHNIH RePORTER
T32 GM008497NIGMS NIH HHSUnited StatesT32GM008497PubMed and NIHNIH RePORTER
UC4 DK104223NIDDK NIH HHSUnited StatesUC4DK104223PubMed and NIHNIH RePORTER

Download CSV of grants

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123192154B-cell depletion improves islet allograft survival with anti-CD45RB.Cell Transplant2014https://conductscience.org/library/papers/23192154PubMed
211981430New mouse model to study islet transplantation in insulin-dependent diabetes mellitus.Transplantation2002https://conductscience.org/library/papers/11981430PubMed
324273001Leptin metabolically licenses T cells for activation to link nutrition and immunity.J Immunol2014https://conductscience.org/library/papers/24273001PubMed
4130384Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunologic responses. Granuloma formation, delayed dermal reactivity and allograft rejection.J Clin Invest1976https://conductscience.org/library/papers/130384PubMed
59133560A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice.Diabetes1997https://conductscience.org/library/papers/9133560PubMed
68425668Effect of STZ administration on islet isograft and allograft survival in NOD mice.Diabetes1993https://conductscience.org/library/papers/8425668PubMed
724056628Effects of preexisting autoimmunity on heart graft prolongation after donor-specific transfusion and anti-CD154.Transplantation2014https://conductscience.org/library/papers/24056628PubMed
823016759Leptin deficiency modulates allograft survival by favoring a Th2 and a regulatory immune profile. [corrected].Am J Transplant2013https://conductscience.org/library/papers/23016759PubMed
99884331A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse.J Clin Invest1999https://conductscience.org/library/papers/9884331PubMed
1014616779Effects of streptozotocin on autoimmune diabetes in NOD mice.Clin Exp Immunol2003https://conductscience.org/library/papers/14616779PubMed
11340468Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays.J Clin Invest1978https://conductscience.org/library/papers/340468PubMed
1221752956Immunosuppressive effects of streptozotocin-induced diabetes result in absolute lymphopenia and a relative increase of T regulatory cells.Diabetes2011https://conductscience.org/library/papers/21752956PubMed
1325131095Resistance of spontaneously diabetic Ins2(akita) mice to allograft tolerance induced by anti-CD154 therapy.Transplant Proc2014https://conductscience.org/library/papers/25131095PubMed
146966615Depressed immunological defence mechanisms in mice with experimentally induced diabetes.Infect Immun1980https://conductscience.org/library/papers/6966615PubMed
15153868Immune responses of diabetic animals. Direct immunosuppressant effects of streptozotocin in mice.Diabetologia1979https://conductscience.org/library/papers/153868PubMed
166432388Alterations in immunological function in streptozotocin-induced murine diabetes mellitus: correction by islet cell transplantation.Clin Immunol Immunopathol1984https://conductscience.org/library/papers/6432388PubMed
1717212763Diabetes induces rapid suppression of adaptive immunity followed by homeostatic T-cell proliferation.Scand J Immunol2007https://conductscience.org/library/papers/17212763PubMed
18347001Impairment of cell-mediated immunity in mutation diabetic mice (db/db).J Immunol1978https://conductscience.org/library/papers/347001PubMed
1923751893Murine animal models for preclinical islet transplantation: No model fits all (research purposes).Islets2013https://conductscience.org/library/papers/23751893PubMed
20711130Recovery of immune system in diabetic mice after treatment with insulin.Horm Metab Res1978https://conductscience.org/library/papers/711130PubMed

See all 24 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
37401013Contribution of animal models to diabetes research: Its history, significance, and translation to humans.J Diabetes Investig2023https://conductscience.org/library/papers/37401013PubMed
29844327Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes.Sci Rep2018https://conductscience.org/library/papers/29844327PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28069641

GET https://conductscience.org/api/papers/v1/28069641/references?page=2